The chemistry behind the color change is elegantly simple. Anthocyanins are the natural pigments that give berries, red cabbage, and hibiscus their vivid hues, and their molecular structure shifts reversibly as pH changes. When food spoils, microbes break down proteins and release volatile amines such as ammonia and trimethylamine, which raise the pH in the package headspace. As the environment becomes more alkaline, the anthocyanin molecules undergo structural transformations that shift their absorbed light from the red end of the spectrum toward blue-green, which the human eye reads as a dramatic darkening. This halochromic behavior makes anthocyanins ideal visual indicators for spoilage, particularly in protein-rich foods where volatile basic nitrogen compounds accumulate rapidly.

Roselle anthocyanins bring a distinct compositional profile to the party. Unlike the berry-derived pigments used in most previous indicator films, roselle is dominated by delphinidin- and cyanidin-based derivatives, which carry higher intrinsic acidity and stronger antioxidant capacity. The researchers suspected these properties could enhance both the pH responsiveness and the bioactivity of the polymer matrix — a hypothesis their experiments largely confirmed. The extraction process itself was straightforward: shade-dried roselle powder was mixed with 80 percent ethanol acidified to pH 2.0, heated at 50 degrees Celsius for an hour, filtered, concentrated under reduced pressure in the dark to prevent photodegradation, and dried into a semi-solid concentrate stored in amber bottles under refrigeration.

Film fabrication followed a solvent-casting route that kept conditions gentle enough to preserve the delicate pigments. Kappa-carrageenan and HPMC were dissolved in a 4:1 weight ratio in distilled water at 80 degrees Celsius, cooled to 50 degrees, and then combined with roselle anthocyanin at concentrations ranging from 0 to 2 percent of the dry polymer weight, with sorbitol as a constant plasticizer. After homogenization and degassing, 30-milliliter aliquots were cast onto Petri dishes and dried at 30 degrees for 24 hours. The resulting films, designated RA0 through RA2, ranged in thickness from 0.047 to 0.076 millimeters — thin enough for practical packaging yet robust enough for characterization.

Mechanical testing revealed a clear trade-off between pigment loading and structural integrity. Tensile strength plummeted from 43.5 megapascals in the control film to just 11.5 megapascals at 2 percent anthocyanin, while elongation at break fell from 18.2 percent to 6.06 percent. The explanation lies in the molecular architecture: anthocyanins carry multiple hydroxyl groups that form hydrogen bonds with the carrageenan and cellulose chains, but at elevated concentrations they disrupt the tight packing of polymer chains, weakening intermolecular cohesion and creating structural heterogeneity that compromises stress distribution. The films become stiffer and more brittle as the pigment crowds the network, restricting chain mobility and limiting plastic deformation before rupture.

Yet the same interactions that weakened the films strengthened their barrier performance. Water solubility dropped from 80.06 percent in the control to 70.27 percent at the highest loading, and the swelling ratio fell from 6.55 to 1.85. By occupying free hydrophilic groups and promoting partial crosslinking within the network, the anthocyanins reduced the availability of sites where water molecules could bind and penetrate. This moisture resistance is a significant advantage for packaging humid foods, where excessive water uptake can dissolve or degrade the film. The films also resisted oil permeation completely in a 24-hour test, thanks to the hydrophilic polysaccharide matrix rejecting non-polar oil molecules, and they retained structural integrity across a pH range from 2 to 12, with only minor disintegration at the most alkaline extremes where ionization of hydroxyl and sulfate groups weakens hydrogen bonding.

Antioxidant activity climbed steeply with pigment concentration, reaching 80.63 percent DPPH radical scavenging at 2 percent loading — a dramatic contrast to the zero activity of the unpigmented control. The phenolic hydroxyl groups on the anthocyanin molecules donate hydrogen atoms to neutralize free radicals, adding an active protective function to the packaging beyond mere indication. Fourier-transform infrared spectroscopy confirmed that the anthocyanins integrated into the matrix without disrupting the primary polymer backbone: the sulfate ester bands characteristic of kappa-carrageenan remained visible in all formulations, while new absorptions associated with aromatic C=C stretching and carbonyl groups verified the pigment’s presence. Thermogravimetric analysis showed the familiar multi-step degradation of polysaccharide films — moisture loss below 200 degrees, plasticizer decomposition between 200 and 300 degrees, and backbone scission up to 450 degrees — with thermal stability essentially maintained despite the bioactive loading.

Biodegradability was assessed through soil burial tests, where the films lost weight continuously over 21 days as soil microbes and enzymes hydrolyzed the hydrophilic polysaccharide matrix. The degradation pattern suggests near-complete breakdown within roughly two months, consistent with other carrageenan-based films that achieve 70 to 100 percent weight loss in 20 to 30 days. This rapid compostability stands in stark contrast to petroleum-based plastics, which persist in the environment for centuries, and underscores the environmental rationale behind the entire approach.

The real proof came from the freshness trial. Button mushrooms, chosen for their high respiration rate and rapid spoilage at room temperature, were packaged with the optimized 2 percent anthocyanin film and stored at 25 degrees Celsius. For the first 8 hours, the mushrooms stayed firm and fresh, and the film held its red color. By 16 hours, transpiration moisture had built up in the package but no off-odors had developed. Between 19 and 24 hours, the mushrooms began to discolor and emit faint odors, and the film started darkening. Beyond 28 hours, strong spoilage odors coincided with the film’s complete red-to-black transition, and by 32 to 36 hours the mushrooms were fully deteriorated — mirrored exactly by the black indicator. The color shift reflects the anthocyanins responding to volatile amines released by spoilage microbes, which raise the local pH and trigger the structural transformation of the pigment molecules.

What makes this work stand out in the crowded field of intelligent packaging is the attention to anthocyanin source as a design variable. Most previous studies have relied on berry pigments, but the roselle derivatives’ higher acidity and antioxidant capacity appear to influence polymer compatibility and functional performance in ways that berry sources do not. The trade-offs are real — mechanical strength suffers at high loadings — but the researchers argue that lower and moderate anthocyanin levels maintain acceptable integrity while prioritizing responsiveness and visual indication. With food waste representing one of the largest inefficiencies in the global supply chain, and with consumers increasingly demanding both sustainability and transparency, a compostable film that doubles as a spoilage alarm offers a compelling glimpse of where packaging is headed: not a passive barrier, but an active, communicating interface between food and the people who eat it.

Subject of Research: pH-responsive κ-carrageenan/HPMC biodegradable films incorporated with roselle anthocyanin for freshness indication

Article Title: pH-responsive κ-carrageenan/HPMC biodegradable films incorporated with roselle anthocyanin for freshness indication

Article References: Patil, C., Bharti, S., & Kumar, A. (2026). pH-responsive κ-carrageenan/HPMC biodegradable films incorporated with roselle anthocyanin for freshness indication. Frontiers in Industrial Microbiology, 4, Article 1784813. https://doi.org/10.3389/finmi.2026.1784813

Image Credits: AI Generated

DOI: 10.3389/finmi.2026.1784813

Keywords: pH-responsive, carrageenan, HPMC, biodegradable, films, incorporated, roselle, anthocyanin, freshness, indication, scientific research

The scale of the underlying analysis is considerable. The authors screened roughly 1,100 records from major scientific databases including Scopus, Web of Science, PubMed, ScienceDirect, and Google Scholar. After removing duplicates and screening titles and abstracts, 530 studies remained for closer inspection, and 430 underwent full-text assessment against predefined eligibility criteria. The final synthesis drew on 183 studies, spanning molecular mechanisms, physicochemical properties, and industrial applications of both natural and synthetic gelling and foaming agents. This systematic approach matters because knowledge about gelation and foaming has long been scattered across different food systems, from confectionery to dairy to beverages, limiting the development of a unified understanding.

At the molecular level, gelation is a story of networks. A gel forms when dissolved biopolymers assemble into a three-dimensional mesh that traps water and other components, producing the firmness, elasticity, and mouthfeel consumers recognize in jellies, desserts, and confectionery. The review details how different agents achieve this through distinct mechanisms. High-methoxyl pectin, the classic jam-setting polysaccharide, requires an acidic environment around pH 2.5 to 3.5 and high sugar concentrations of 55 to 75 percent. The acid reduces electrostatic repulsion between negatively charged pectin molecules, while sugar binds available water, allowing hydrogen bonds and hydrophobic interactions between methyl ester groups to stabilize junction zones into a thermoreversible network.

Low-methoxyl pectins and alginates take a different route entirely: ionic cross-linking. Alginate, extracted from brown seaweed, gels in the presence of calcium ions through the well-known egg-box model, in which divalent cations nest between the guluronate regions of adjacent polymer chains. This chemistry powers the spherification technique beloved of molecular gastronomy, where an alginate-containing liquid dropped into a calcium chloride solution instantly forms a thin, flexible membrane around each droplet, producing caviar-like spheres. Carrageenans from red seaweed follow yet another path, undergoing a coil-to-helix transition upon cooling before metal ions such as potassium and calcium aggregate the helices into networks. The ion type dictates texture: potassium yields firm, brittle gels with kappa-carrageenan, while calcium produces softer, more elastic structures with the iota form.

Agar demonstrates perhaps the most dramatic thermal behavior of any hydrocolloid. When heated above 85 to 95 degrees Celsius, agarose chains float as random coils; on cooling to between 32 and 45 degrees, they align into ordered double helices stabilized by hydrogen bonds, which then aggregate into a rigid three-dimensional network. The large gap between setting and melting temperatures gives agar gels exceptional thermal stability, remaining solid at room temperature and beyond. This hysteresis, combined with high clarity and low syneresis, explains why roughly 90 percent of extracted agar serves as a gelling agent in meat and fish products and as a texture enhancer in dairy, and why it has become the gelatin substitute of choice for vegetarian and vegan formulations.

Gelatin, the workhorse of confectionery, operates through temperature-induced protein assembly. Derived from the hydrolytic degradation of collagen, it consists largely of glycine, proline, and hydroxyproline, organized into alpha, beta, and gamma polypeptide chains. Dissolved in hot water, its triple-helix structure unwinds into individual strands; as the solution cools, these strands re-form hydrogen bonds and hydrophobic interactions, weaving a mesh that traps water and sets into the familiar semi-solid. Beyond desserts, gelatin retains juices in canned meats, stabilizes marshmallows and gummy candies, and even serves as an edible film material, though its animal origin increasingly conflicts with consumer demand for plant-based alternatives.

Foaming, the review’s second focus, is governed by a different physical principle: the stabilization of gas bubbles within a liquid or semisolid matrix. Proteins act as natural foaming agents because they are amphiphilic, carrying both hydrophilic and hydrophobic regions. When egg whites are beaten, proteins such as ovalbumin and ovotransferrin unfold and realign at the air-water interface, forming a thin elastic film that encapsulates air and lowers surface tension. Surfactants like soy lecithin and monoglycerides perform the same job more efficiently, aligning at the interface to prevent bubble coalescence. In whipped cream, partially coalescing fat globules form a network that locks air bubbles in place, reinforced by a secondary protein layer, producing the smooth, creamy texture essential to consumer satisfaction.

The practical stakes of foam stability extend across the entire food landscape. In bakery, angel food and chiffon cakes depend on egg-white foams that expand during baking, with cream of tartar added to lower the pH and enhance stability. In beverages, the head on beer and the microfoam on a cappuccino both rely on surface-active proteins forming resilient layers around bubbles. In gluten-free baking, where the gluten network is absent, methylcellulose and egg whites provide the aeration and structure needed for a light crumb. Even fats can sabotage the process: oils disrupt the films around air bubbles, forcing formulators to adjust ingredient proportions and processing techniques carefully.

The review also spotlights emerging alternatives driven by the clean-label movement. Aquafaba, the cooking water from chickpeas and other legumes, contains proteins, polysaccharides, and saponins that give it foaming capacity and stability comparable to egg whites in certain applications, making it attractive for vegan and allergen-free formulations. Xanthan gum, produced by bacterial fermentation, remains stable across a remarkable pH range of 2.0 to 12.0 and in high-salt environments, excelling as a foam stabilizer and suspension agent. Yet natural ingredients bring their own problems: batch-to-batch variability in composition, molecular weight, and purity, driven by species, harvest season, and extraction method, can shift gel strength and viscosity unpredictably, complicating industrial standardization.

The authors conclude that the future lies in hybrid systems and advanced processing. Combining polysaccharides with plant proteins may deliver enhanced stability, resistance to thermal degradation, and reduced syneresis in clean-label formulations, while technologies such as high-intensity ultrasound, cold plasma, and high-pressure processing offer ways to tailor the interfacial behavior and rheological properties of non-animal biopolymers to match conventional agents. Ion-induced gelation with gellan gum under high pressure, which sets cold-set desserts without heating, hints at how processing innovation can preserve temperature-sensitive ingredients. Bridging fundamental knowledge of macromolecular interactions with industrial-scale application, the review argues, will be essential for building the next generation of stable, sustainable, and sensory-optimized foods, ensuring that the invisible chemistry inside every jelly and foam keeps pace with what consumers expect on the label.

Subject of Research: Mechanisms and applications of gelling and foaming agents in food systems

Article Title: Review on Gelling and Foaming Agents in Food: Mechanism and Applications

Article References: Kassa, M. G., Teferi, D. A., Satheesh, N., & Asemu, A. M. (2026). Review on Gelling and Foaming Agents in Food: Mechanism and Applications. Food Science & Nutrition, 14(10), Article e72437. https://doi.org/10.1002/fsn3.72437

Image Credits: AI Generated

DOI: 10.1002/fsn3.72437

Keywords: gelling agents, foaming agents, hydrocolloids, pectin, gelatin, agar, carrageenan, alginate, aquafaba, food texture, clean label, plant-based proteins

To understand the problem, it helps to understand how seaweed gel is actually made. The dominant extraction method is an alkaline process, in which raw seaweed—most importantly the red alga Gracilaria, which contains roughly 30 percent agar and supplies about 53 percent of global agar market demand—is treated with strong alkali. This treatment serves a precise chemical purpose: it converts L-galactose-6-sulfate into 3,6-dehydrated L-galactose, stripping sulfate groups from the polysaccharide chains that would otherwise weaken the gel. The full production line runs from raw seaweed through alkali treatment, neutral cleaning, acidification, bleaching, gel cooking, filtration, cooling, dehydration, and drying. At every stage, chemistry is working to transform a slippery marine plant into a stable, marketable colloid.

That chemistry comes at a cost. During alkali treatment, the alkali attacks the seaweed cell wall, dissolving pigments, polysaccharides, and proteins into the solution, which turns from transparent to a dark liquid known in the trade as black lye. Factories typically reuse industrial lye two or three times, but once the organic concentration climbs too high and the liquid becomes viscous, it can no longer serve. Roughly 30 percent of the alkali remains trapped in the seaweed itself and must be washed out with repeated rinsing and acidification. Producing a single ton of seaweed gel consumes between 8.08 and 10.5 tons of alkali and generates approximately 460 to 600 tons of low-concentration alkali washing wastewater. In Fujian Province, China’s leading seaweed-processing region, nearly 100,000 tons of high-COD waste lye are produced annually; if alkali is reused more than seven times, the chemical oxygen demand can exceed 100,000, making the process unsustainable.

The solid waste stream is equally troubling. Filtration of the gel liquor is hindered by the colloid’s tendency to form a film, so producers add perlite—a porous volcanic glass with a large specific surface area—as a filter aid. The result is a residue that mixes perlite with a substantial load of organic matter. Each ton of seaweed gel generates roughly 2.5 tons of waste residue on a dry basis, and Fujian Province alone produces more than 35,000 dry tons annually. Left to accumulate, this residue decomposes, releasing methane and sulfides and other pollutants. The residue is rich in resources—about 70 percent perlite, along with trehalose, protein, and polyphenols—yet aside from minimal fertilizer recycling and some use as animal feed, most of it ends up as industrial landfill.

The review systematically evaluates the treatment options available for waste lye, and finds most of them wanting. Neutralization followed by activated sludge degradation at sewage plants, the current industrial default, wastes the active substances dissolved in the lye and requires large quantities of acid. Activated carbon adsorption can clean filtered lye, but saturated carbon cannot be reused, creating new disposal problems. Electrochemical oxidation on Ru-iridium titanium electrodes can rapidly strip alkali from seaweed and recover caustic through electrolytic cell reactions—one study reported continuous alkali recovery over 20 days in a bipolar chamber—but it does not recover the organic components. Even green approaches such as using algae to absorb nitrogen and phosphorus from agar wastewater leave the question of concentrated waste lye unresolved.

The most promising lye technology, the authors argue, is electrodialysis combined with membrane concentration. Electrodialysis uses an electric field to drive charged ions selectively across membranes, separating them from the solution; it is already widely used in food processing, salt production, and wastewater treatment. In studies of seaweed-derived waste lye specifically, electrodialysis achieved a cumulative alkali recovery rate of 37 percent while separating alkali from organic matter with low energy consumption and no phase change. The authors’ own group reported a chemical oxygen demand removal rate of 69.97 percent and an alkali recovery rate of 45.31 percent for electrodialysis-treated lye. Membrane concentration adds another layer of capability: multistage membrane systems have recovered tea polyphenols with retention rates of 70 to 83.8 percent, and nanofiltration membranes have cleaned paper-making black lye to reuse standards. New alkali-stable membranes, including quaternized graphene oxide composites that survived 32 days in 2 mol/L sodium hydroxide at 60 degrees Celsius, are making these processes increasingly robust.

For the solid residue, the review champions a hybrid of enzymatic and chemical degradation over calcination, which is costly and can create air pollution, or acid hydrolysis alone, which generates waste acid. Enzymes are gentle catalysts that cleave the glycosidic bonds of polysaccharide macromolecules, producing low-molecular-weight oligosaccharides without generating additional waste. In a key demonstration, the research team enzymatically treated nearly half of the polysaccharides in the residue—excluding the perlite—and recovered specific active oligosaccharides including neoagarobiose, neoagarotetraose, cellobiose, and cellotriose, which initially cleaned the pores of the perlite. Food-grade hydrochloric acid and hydrogen peroxide then degraded the remaining polysaccharides lodged inside the perlite pores, restoring the filter aid’s structure. The recovered perlite achieved a permeability of 2.61 Darcy, meeting reuse standards, and performed comparably to commercial perlite in subsequent gel extraction.

Yet significant scientific puzzles remain, and the review devotes considerable attention to them. During electrodialysis, charges generated in the process are adsorbed by organic substances, which accumulate on the surface of the permeable membrane and reduce the lye recovery rate. Related studies have shown that organic compounds containing benzene rings adsorb especially strongly onto anion exchange membranes, restricting transmembrane ion migration, and that sodium ions alter the internal molecular structure of organic polysaccharides in ways that change how they foul membranes. On the residue side, the structural activity and recovery of organic polysaccharides depend on the specific structure of the enzymes used, and organic material conversion involves energy interactions during solid-liquid separation that are not yet fully understood. These mechanisms, the authors contend, are the critical barriers to industrial-scale recovery of organic active substances from seaweed gel waste.

To crack those mechanisms, the review proposes a concrete analytical toolkit. Trace-charge analysis combined with scanning electron microscopy can quantify how organic active substances aggregate and how charges adsorb and release on membrane surfaces, while charge diffusion models can simulate charge transport during electrodialysis with membrane concentration. For the residue, microcalorimetry and thermodynamic models can track the energy changes that occur as specific enzymes act on organic matter, and Fourier transform infrared spectroscopy, X-ray fluorescence, and X-ray photoelectron spectroscopy can reveal how elemental composition and chemical bonding change during recovery. Analogous work on lignin and sugarcane bagasse has already demonstrated that pyrolysis behavior and potential energy shifts correlate with structural changes during enzymatic hydrolysis, providing a template the seaweed field can follow.

The stakes extend well beyond one industry. Seaweed aquaculture reached approximately 36.3 million tons globally in 2021—97 percent of it cultivated—and China alone produced 2.72 million tons in 2022, with Fujian Province accounting for nearly 48 percent of that output and 60.36 percent of national seaweed gel production. As the blue industry expands, the review’s framework offers a way to close the loop: recover the alkali, reclaim the perlite, extract the oligosaccharides, and return cleaner water to coastal ecosystems. If electrodialysis and enzyme chemistry can be scaled from laboratory benchmarks to factory floors, the mountains of black lye and perlite-laden sludge that currently shadow the seaweed gel industry could become feedstocks rather than liabilities—turning one of aquaculture’s messiest byproducts into one of its most elegant success stories.

Subject of Research: Waste reduction and resource recovery technologies in seaweed gel (agar and carrageenan) production

Article Title: Frontier review of key reduction technologies and resource utilization of waste during the seaweed gel production process

Article References: Luo, X., Wu, Y., Wang, S., Xiong, Z., Du, X., Zheng, M., Zhu, Y., Jiang, Z., Li, Q., Ni, H., Li, Z., & Chen, Z. (2024). Frontier review of key reduction technologies and resource utilization of waste during the seaweed gel production process. Blue Biotechnology, 1(1), Article 12. https://doi.org/10.1186/s44315-024-00013-7

Image Credits: AI Generated

DOI: 10.1186/s44315-024-00013-7

Keywords: seaweed gel, agar, carrageenan, waste lye, electrodialysis, membrane concentration, perlite recovery, enzymatic degradation, polysaccharides, oligosaccharides, wastewater treatment, blue biotechnology

What makes marine carbohydrates so chemically interesting is their structural diversity. Polysaccharides extracted from seaweeds, sponges, shellfish and marine bacteria can carry sulfate groups in patterns that differ from species to species, form glycosidic linkages that are uncommon in terrestrial plants, and adopt branched architectures that change how they interact with biological targets. Fucoidans from brown algae, carrageenans from red algae, chitin and chitosan derivatives from crustacean shells, and sulfated glycosaminoglycan-like molecules from marine animals all fall into this category. Because the precise arrangement of sulfate groups and sugar units determines how these molecules bind to proteins, enzymes and cell surfaces, even subtle structural differences can translate into dramatically different biological effects.

That sensitivity to structure is precisely why these molecules have attracted attention across so many therapeutic areas. The review documents reported antiviral, anticoagulant, immunomodulatory and antitumor activities for marine-derived carbohydrates and their derivatives, alongside material properties that make them useful in drug delivery systems, wound dressings and tissue engineering scaffolds. Sulfated polysaccharides, for example, can interfere with viral attachment and entry by mimicking the charged surfaces that viruses normally latch onto, while alginate-based materials have become mainstays in encapsulation and wound-care applications because of their gentle gelling behavior and biocompatibility.

The clinical story of marine-inspired drugs is older than many readers might expect. The review’s authors anchor their timeline to cytarabine, an antileukemia drug approved in the United States in 1969, which traces its chemical inspiration to nucleosides originally isolated from a Caribbean sponge. Although cytarabine is not itself a carbohydrate in the polysaccharide sense, it established a crucial precedent: molecules derived from marine organisms could survive the full gauntlet of preclinical testing, regulatory scrutiny and clinical use. Later products built on alginate, carrageenan and other marine raw materials followed, extending the family of carbohydrate-based medicines into areas such as wound management, drug formulation and symptomatic treatment.

Today, the pipeline is broader than ever. The review surveys clinical-stage candidates derived from marine carbohydrates currently being evaluated for viral infections, cancer, metabolic disorders, tissue repair, cystic fibrosis and neurological disease. This breadth reflects both the versatility of the molecules and the maturity of the field: what was once a collection of exploratory extracts has become a portfolio of defined candidates moving through controlled trials. Yet the authors are careful to note that the distance between a promising laboratory result and an approved product remains substantial, and that the obstacles are not primarily about discovering new activities.

The central challenge, according to the review, is reproducibility. The biological activity of a marine polysaccharide depends on its molecular weight, its sulfation pattern and its monosaccharide composition, but all three of these parameters can vary with the species from which the material is harvested, the season in which it is collected, and the extraction and processing methods used to isolate it. A batch of fucoidan gathered from one coastline in spring may differ measurably from a batch of the nominally same polymer collected elsewhere in autumn. For a regulatory agency, such variability is a serious problem, because a drug must deliver the same molecule, with the same quality attributes, every single time.

Solving that problem requires the kind of systematic thinking that the review tries to encourage. The authors argue that marine carbohydrates have too often been studied in terms of individual biological activities, with each research group reporting a single effect in isolation, while clinical development demands an integrated understanding of how structure, production, quality control and mechanism of action fit together. A candidate cannot advance if researchers cannot define its composition precisely, manufacture it consistently and explain how it works at the molecular level. The review therefore treats approved drugs and clinical candidates not just as success stories, but as case studies in how these elements can be aligned.

The priorities for future development that the authors identify are correspondingly practical. They call for reliable production methods based on cultivation, fermentation or enzymatic processing, which would decouple drug supply from wild harvesting and reduce batch-to-batch variation. They emphasize the need for improved quality control that combines structural characterization with activity-based assays, so that manufacturers can verify not only what a batch contains but what it does. They also stress the importance of validating molecular targets and mechanisms of action, and of conducting more rigorous pharmacokinetic and safety studies, areas in which complex carbohydrates have historically lagged behind small-molecule drugs because of their size, heterogeneity and analytical difficulty.

Achieving these goals, the review concludes, will require collaboration across disciplines that do not always work together. Senior and co-corresponding author Guangli Yu of the Ocean University of China notes that progress will depend on close cooperation among researchers in glycoscience, analytical chemistry, synthetic biology, materials science and clinical research. Co-corresponding author Chao Cai, also of the Ocean University of China, shares responsibility for the work, which was conducted within the Key Laboratory of Marine Drugs under the Ministry of Education and the Shandong Key Laboratory of Glycoscience and Glycotherapeutics. The interdisciplinary framing is deliberate: no single field currently possesses all the tools needed to characterize, manufacture and clinically validate a heterogeneous natural polymer.

The significance of the review lies less in any single discovery than in its synthesis. By following a clinical timeline that stretches from a 1969 leukemia drug to today’s trials in virology, oncology, metabolic disease and neurology, it demonstrates that marine carbohydrate therapeutics are not a speculative frontier but an evolving branch of pharmacology with a documented track record. The structural uniqueness of ocean-derived sugars, once a curiosity, is now understood as a design resource, and the field’s remaining challenges are the familiar ones of manufacturing, characterization and clinical evidence. If the collaborative agenda the authors describe takes hold, the next chapters of this timeline may be written not by chance discoveries in tide pools, but by engineered production systems capable of delivering the ocean’s chemistry with pharmaceutical precision.

Subject of Research: Marine carbohydrate-based drug development and clinical translation

Article Title: Marine carbohydrate therapeutics: from structural diversity to clinical translation

Article References: Marine carbohydrate therapeutics: from structural diversity to clinical translation. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: marine carbohydrates, polysaccharides, fucoidan, alginate, carrageenan, drug development, clinical trials, glycoscience, sulfation, antiviral, anticoagulant, Ocean University of China

The timing of the study is significant. Tanzania is riding a remarkable rebound. After wild seaweed stocks were depleted in the late 1970s, the country transitioned to commercial cultivation in 1989 with seedlings introduced from the Philippines, and production climbed from 7,000 tons of dry weight in 2005 to a peak of 17,600 tons in 2015. A crash followed after 2016, driven by climate-related stress, disease outbreaks including the notorious ice-ice syndrome, and epiphyte infestations, dragging output down to about 11,000 tons by 2018 to 2020. But recent policy reforms, including reduced export permit fees, helped production surge to 25,426 metric tons in 2023, with quarterly monitoring showing a 52 percent year-over-year increase in the third quarter of that year.

Despite that recovery, Tanzania still contributes only about 0.4 percent of global seaweed output, in a market where Asia dominates with 97 percent of the roughly 35.8 million tons cultivated worldwide in 2023. Africa produces an estimated 120,000 metric tons of red eucheumatoid seaweeds annually, and more than 90 percent of that comes from Tanzania. The gap between what the country produces and what it could produce, given its rich native biodiversity in nutrient-poor but sun-drenched coastal waters, is what the researchers describe as untapped potential. The question their study poses is why that potential remains locked, and their answer points not to the farms themselves but to everything that happens after harvest.

The research team worked across six sites in five coastal regions: Pangani in Tanga, Kigamboni in Dar es Salaam, Bagamoyo and Juani in Pwani, Somanga in Lindi, and Naumbu in Mtwara. These locations were chosen because each supports an average of around 800 people involved in the seaweed industry. Using a mixed-methods design, the team surveyed 208 stakeholders, from farmers and traders to suppliers, fishers, processors, transporters, and cooperative leaders, selected through proportional stratified sampling to ensure representation. They supplemented the surveys with 55 semi-structured interviews with key informants, including district fisheries officers and marine aquaculture experts, focus group discussions of roughly ten participants at each site, and direct participant observation of village life and farming operations.

The demographic picture that emerged is strikingly gendered. Women made up 74 percent of survey respondents, and 94 percent of respondents identified women as the primary actors in production. Yet only about 30 percent of these women reported owning the plots they farm; the remaining 70 percent work as laborers on land they do not control. Most respondents were of working age, with nearly 90 percent between 26 and 50 years old, and 85 percent had participated in seaweed farming for less than five years, suggesting a recent influx of newcomers drawn by economic necessity. Incomes were low across the board, with 88.5 percent earning below 300,000 Tanzanian shillings per month, and households were large, with 61.5 percent reporting six to ten members.

Income generation was the dominant motivation for farming, cited by about 40 percent of respondents, far ahead of social influence, training exposure, or village initiatives. Notably, ecological awareness played almost no role: roughly 86 percent of respondents could not clearly explain how seaweed farming contributes to marine environmental protection, even though the practice is widely regarded as one of the most sustainable forms of aquaculture, requiring no fertilizers, pesticides, land, or freshwater. Farmers participate because the work is flexible enough to combine with domestic responsibilities and because declining capture fisheries have left few alternatives, not because they see themselves as stewards of a climate-friendly industry.

The technical picture is one of stagnation. More than 96 percent of respondents rely on traditional shallow-water, off-bottom cultivation using peg-and-rope methods, with minimal adoption of floating lines or tubular nets that could buffer crops from warming waters. Around 70 percent said their current scale of operations does not yield sufficient economic returns, and only 12 percent reported any involvement in value addition over the past five years. Access to inputs such as ropes, floats, and boats was lacking for 76 percent of respondents, and fewer than 30 percent received extension services, which were described as irregular, project-based, and often occurring less than twice a year. Perceptions of the policy framework scored a mean of just 2.73 on a six-point satisfaction scale.

The market structure may be the most damning finding. Approximately 80 percent of harvested seaweed is sold dried to intermediaries or exporting firms, and 92 percent of respondents did not know where their product ultimately went. A small group of firms, including Tanga Seaweed, ZANEA, King David, and Ledo Biashara, dominates buying and exporting, with a spatially uneven presence that leaves some communities with no buyer at all or forced to accept reduced prices. Local demand is nearly absent, with 70 percent of respondents reporting no household consumption of seaweed products, and exposure to seaweed goods largely confined to occasional events such as Nanenane Farmers’ Day and the Dar es Salaam International Trade Fair. With so few buyers, farmers have almost no bargaining power, and the sector remains locked in exporting low-value raw dried biomass.

The study’s central argument is that Tanzania’s problem is not production capacity but structural fragmentation. Production is growing without corresponding improvements in aggregation, processing, market transparency, or coordination, so expansion translates into more labor rather than more value. The researchers point to experiences in Indonesia, the Philippines, and Europe, where supply chain upgrading has depended on coordinated investment in processing capacity, quality standards, and institutional support. They also highlight a governance gap: the farmers who produce the crop, most of them women, have limited representation in market negotiations and policy processes, and Tanzania lacks a dedicated seaweed policy. Inclusion without access to assets, credit, and decision-making, the authors warn, does not translate into empowerment.

Yet the study is not only a diagnosis of failure. Respondents identified concrete opportunities: strengthening producer groups and collection systems for bulk handling, investing in basic storage and handling infrastructure to improve quality, supporting emerging local enterprises in collection and small-scale processing, and deepening ties with research institutions such as the Institute of Marine Sciences, the University of Dar es Salaam, and Sokoine University of Agriculture. Embedding seaweed farming within broader coastal development and ocean sustainability strategies, the authors argue, could improve livelihoods while building more resilient marine economies. The future of the sector, they conclude, depends less on growing more seaweed and more on reorganizing how value is created and distributed along the chain, a structural transition that would determine whether Tanzania’s seaweed boom finally pays off for the women who make it happen.

Subject of Research: The seaweed supply chain, market constraints, and livelihood opportunities for coastal farming communities in mainland Tanzania

Article Title: Challenges and opportunities of seaweed supply chain in mainland Tanzania

Article References: Katikiro, R. E., & Michael, A. (2026). Challenges and opportunities of seaweed supply chain in mainland Tanzania. Discover Oceans, 3(1), Article 29. https://doi.org/10.1007/s44289-026-00142-4

Image Credits: AI Generated

DOI: 10.1007/s44289-026-00142-4

Keywords: seaweed farming, Tanzania, supply chain, carrageenan, coastal livelihoods, women farmers, value addition, blue economy, aquaculture, market access, Kappaphycus alvarezii, Eucheuma denticulatum

The research, led by Sweeta Peter Emerson and Seena Jose at the National Centre for Aquatic Animal Health, Cochin University of Science and Technology, together with colleagues in India, focused on heterotrophic diazotrophic bacteria, or HDB. Unlike the familiar photosynthetic cyanobacteria that long dominated textbook accounts of marine nitrogen fixation, heterotrophic diazotrophs are non-photosynthetic microbes that nonetheless possess nitrogenase, the oxygen-sensitive enzyme complex that converts dissolved N2 into bioavailable ammonia. Recent global surveys, including metagenomic analyses spanning the Pacific, Atlantic and Indian Oceans, have revealed that these bacteria are far more abundant in the sunlit ocean than cyanobacteria, and estimates place total marine nitrogen fixation at roughly 60 to 175 teragrams of nitrogen per year. HDB have even been implicated in the explosive Sargassum blooms of the Great Atlantic Sargassum Belt, where they made up 76 percent of the diazotroph community on offshore seaweed.

Catching these organisms in the act of nitrogen fixation is notoriously difficult in the laboratory. Nitrogenase is destroyed by oxygen, so diazotrophs must be grown under low-oxygen conditions or on media that create an oxygen gradient. The Indian team took a deliberately culture-based approach. Thallus sections of K. alvarezii, supplied by the seaweed company Sea6 Energy from farms in Tuticorin, Tamil Nadu, were surface sterilized, sliced into cross and longitudinal sections, and incubated for fifteen days on a nitrogen-free marine medium. Colonies emerging from inside the tissue, from the outer sheath, and from the surrounding surface were picked with fine capillary tubes and purified through repeated streaking on nitrogen-free semisolid medium, a classic technique that favors bacteria able to grow without any fixed nitrogen source.

The harvest was impressive. Seventy-nine isolates representing nineteen distinct morphologies were obtained, and sequencing of the 16S rRNA gene revealed that they belonged to twenty-three species spanning three phyla, four classes, seven orders and thirteen genera. Alphaproteobacteria dominated the collection at 62 percent, followed by Flavobacteriia at 22 percent, Gammaproteobacteria at 11 percent and Bacilli at 5 percent. The genera recovered included Yangia, Salipiger, Mangrovicoccus, Tritonibacter, Pseudooceanicola, Roseibium, Thalassospira, Oceanobacillus, Alteromonas, Marinobacter, Pseudomonas, Stutzerimonas and Tenacibaculum. Tenacibaculum mesophilum was the single most frequently recovered species, with seventeen isolates, followed by Tritonibacter mobilis. Different genera occupied different microhabitats: Oceanobacillus appeared only inside the tissue sections, Stutzerimonas stutzeri and Pseudomonas khazarica only on the outer surface, and Salipiger only in the sheath layer, while several genera such as Alteromonas and Thalassospira were found across all three zones.

The decisive test came from the nifH gene, which encodes the iron protein subunit of the molybdenum nitrogenase and serves as the standard molecular marker for diazotrophic potential. Using the degenerate IGK3/DVV primer pair, one of the best-performing primer sets for capturing nifH diversity across bacterial groups, the researchers amplified the gene from eight of the seventy-nine isolates, roughly 11 percent. Seven of the eight nifH-positive strains were Alphaproteobacteria, including Yangia mangrovi, Yangia pacifica, Salipiger sp., three Thalassospira strains and Mangrovicoccus ximenensis, while the eighth was the Gammaproteobacterium Stutzerimonas stutzeri. No nifH signal was detected among the Flavobacteriia or Bacilli isolates.

The team then went to considerable lengths to confirm that these sequences represented genuine nitrogenase rather than look-alike proteins. Translated NifH amino acid sequences showed 98 to 100 percent identity to verified nitrogenase iron proteins in public databases, with strong similarity to the reference NifH of Azotobacter vinelandii and less than 10 percent similarity to pseudo-NifH homologs such as bchX, bchL, chlL, minD and parA, which participate in pigment biosynthesis rather than nitrogen fixation. Phylogenetic trees built from the amino acid sequences placed the seaweed isolates in a tight cluster with authentic Group I nitrogenases, clearly separated from the chlorophyllide and protochlorophyllide reductase clades, which diverged by 83 percent bootstrap support. This careful discrimination matters, because degenerate nifH primers are known to occasionally co-amplify these homologous genes.

Beyond nitrogen fixation, the study uncovered another growth-promoting trait. Three of the nifH-positive isolates, Stutzerimonas stutzeri MCCB411, Yangia mangrovi MCCB413 and Mangrovicoccus ximenensis MCCB422, were screened for production of indole-3-acetic acid, the principal auxin plant hormone that also acts as a signaling molecule in seaweed-microbe interactions. All three produced the hormone in culture, turning pink in the classic Salkowski colorimetric assay, and production rose two- to four-fold when the amino acid tryptophan was added to the medium, indicating a tryptophan-dependent biosynthetic pathway. Yangia mangrovi was the most prolific producer. Auxin production by seaweed-associated bacteria has previously been linked to bud formation in Gracilaria dura and to gall formation in Prionitis lanceolata, so the trait could plausibly influence the growth and morphogenesis of Kappaphycus as well.

The broader ecological picture is one of a functional microbiome rather than a random assortment of hitchhikers. Members of the Roseobacter clade, which made up 14 percent of the isolates, are known rapid colonizers of algal surfaces. Salipiger species tolerate hypersaline conditions and possess genes for osmolyte production, potentially helping the host cope with salinity stress. Mangrovicoccus and Pseudomonas produce polysaccharide-degrading enzymes, Pseudomonas is known to regulate zoospore settlement and morphogenesis in green algae, and Stutzerimonas stutzeri is a biofilm-forming species whose close relative Pseudomonas stutzeri BAL361 is a well-characterized marine diazotroph capable of fixing nitrogen at micromolar oxygen levels by forming microaerophilic aggregates. Diazotrophic activity by Yangia species has even been detected in the equatorial Indian Ocean, and sequenced Yangia and Salipiger genomes encode the full complement of nifHDK and accessory genes required for nitrogen fixation.

The authors are careful about the limits of their evidence. A color change in the nitrogen-free medium from green to blue, indicating ammonia production, occurred in many isolates that did not amplify nifH, confirming that this visual cue is only suggestive and can reflect non-diazotrophic bacteria feeding on nitrogen released by genuine fixers. Because the study relied entirely on culture-based methods, the isolates are conservatively described as K. alvarezii-associated rather than definitively endophytic, and no direct functional measurements such as acetylene reduction assays or 15N2 incorporation experiments were performed. Those validation steps, the team notes, remain the essential next stage before these strains can be deployed in seaweed farming.

Even so, the implications are striking for an industry built on this single alga. Kappaphycus farming supports coastal livelihoods across India, Southeast Asia and the tropical Pacific, and the seaweed’s ability to grow in nitrogen-poor waters has long puzzled biologists, since more than 95 percent of seawater nitrogen exists as dissolved N2 gas that most organisms cannot touch. If the associated diazotrophs documented here are confirmed to fix nitrogen in situ, they could explain that resilience and open the door to microbiome-based interventions, from probiotic inoculants to selective breeding of host-microbe pairings, aimed at boosting yields of a crop that quietly supplies the carrageenan thickening everything from ice cream to pharmaceuticals. The red seaweed, it turns out, may farm its own fertilizer.

Subject of Research: Culturable nitrogen-fixing bacteria associated with the red seaweed Kappaphycus alvarezii

Article Title: Diversity and diazotrophic potential of culturable bacteria associated with the red seaweed Kappaphycus alvarezii

Article References: Emerson, S. P., Jose, S., Golla, A. P., Kumar, A., Nori, S. S., Suryanarayanan, S., Singh, I. S. B., & Joseph, V. (2026). Diversity and diazotrophic potential of culturable bacteria associated with the red seaweed Kappaphycus alvarezii. Discover Oceans, 3(1), Article 31. https://doi.org/10.1007/s44289-026-00141-5

Image Credits: AI Generated

DOI: 10.1007/s44289-026-00141-5

Keywords: Kappaphycus alvarezii, diazotrophic bacteria, nitrogen fixation, nifH gene, seaweed microbiome, Alphaproteobacteria, indole-3-acetic acid, carrageenan, seaweed farming, marine microbiology, heterotrophic diazotrophs, 16S rRNA

The sheer diversity of these materials is striking. Chitin, the second most abundant biopolymer on Earth after cellulose, forms the structural skeleton of crustacean shells and fungal cell walls. When its acetyl groups are stripped away through deacetylation, it becomes chitosan, a positively charged polysaccharide whose amine groups give it antimicrobial activity, mucoadhesive behavior, and the ability to form gels, films, and nanoparticles. Agar and carrageenan, both sulfated or galactan-based polysaccharides extracted from red seaweeds, are already familiar workhorses of the food industry as gelling and thickening agents. Alginate, harvested from brown seaweeds, is famous for its ability to form stable hydrogels through the so-called egg-box model, in which divalent calcium ions bridge guluronic acid blocks on adjacent polymer chains. Ulvan, extracted from green seaweeds of the genus Ulva, remains comparatively obscure but carries sulfate groups and uronic acids that have attracted attention for immunomodulatory activity. Collagen and gelatin, meanwhile, come largely from fish skins, scales, and bones, offering an alternative to bovine and porcine sources that sidesteps both religious dietary restrictions and concerns about bovine spongiform encephalopathy.

One of the review’s most valuable contributions is its honest accounting of extraction yields, which vary enormously depending on both the source organism and the processing route. The authors report that chitosan-containing shrimp-shell residue yielded just 10.56 percent in one process, while chitosan extracted from mixed fishery waste reached 20.45 percent. Alginate from selected brown seaweeds delivered yields between 29.28 and 30.9 percent, agar from the red alga Gracilaria corticata ranged from 20.91 to 33 percent, and collagen from the skin of the Amazonian freshwater fish pirarucu came in at 27.8 percent. These numbers matter because yield, purity, and molecular weight collectively determine whether a marine biopolymer can be produced economically at industrial scale. A process that recovers a third of the available polymer is a very different commercial proposition from one that recovers a tenth, and the review makes clear that no single extraction protocol has yet emerged as the standard.

That variability is driving a wave of innovation in green extraction technology. Traditional chitin production relies on harsh mineral acid demineralization and alkaline deproteinization, generating significant chemical waste. Newer approaches replace or supplement these steps with ultrasound-assisted processing, subcritical water hydrolysis, supercritical carbon dioxide, and even ionic liquids that can dissolve chitin directly and allow deproteinization under milder conditions. Agar recovery has been boosted by combining subcritical water extraction with moderate electric fields, while collagen has been pulled from marine sponges and Atlantic cod skins using nothing more aggressive than water acidified with carbon dioxide. These techniques promise lower environmental footprints, better preservation of heat-sensitive bioactivity, and in some cases improved thermal stability and water-holding capacity in the final product, properties that matter enormously when the polymer is destined for a food matrix rather than a laboratory beaker.

The biological activities attributed to these polymers form the scientific heart of the nutraceutical case. Chitosan and its oligomers display broad-spectrum antibacterial activity, thought to arise from the electrostatic interaction between the polymer’s protonated amine groups and the negatively charged membranes of bacterial cells, disrupting permeability and ultimately killing the microbe. Chitosan has also been shown in animal models to ameliorate chemically induced ulcerative colitis by strengthening the intestinal barrier and reshaping the gut microbiome. Carrageenan fragments, particularly low-molecular-weight kappa-carrageenan hexamers, have demonstrated anti-inflammatory effects in macrophage cell lines by inhibiting the CD14 receptor pathway. Fucoidan, a sulfated polysaccharide from brown seaweeds, has activated natural killer cells in mice and reduced the viability of lung carcinoma and melanoma cells in vitro. Alginate acts as a soluble dietary fiber that slows gastric emptying and blunts postprandial glycemic spikes, an effect documented in humans with diabetes as early as the 1990s. Neoagaro-oligosaccharides derived from enzymatic hydrolysis of agarose show prebiotic effects, feeding beneficial anaerobic gut bacteria.

Yet the review is refreshingly blunt about the gap between laboratory promise and clinical proof. Recent human evidence genuinely supports the oral use of fish-derived collagen peptides, with clinical studies reporting improvements in skin elasticity, cellulite severity, and hair shaft diameter, supported by pharmacokinetic data showing that orally administered low-molecular-weight collagen peptides are absorbed and circulate in the bloodstream. Beyond collagen, however, most of the headline-grabbing health effects remain preclinical. Chitosan-alginate delivery systems, for example, have shown impressive results in animal models of inflammatory bowel disease, where colon-targeted microspheres co-delivering synbiotics and nanozymes ameliorated disease symptoms, and in controlled-release systems for antidiabetic peptides derived from rapeseed. But these are mouse and cell studies, not double-blind human trials. Similarly, the immunostimulatory effects of fucoidan on dendritic cells and the fat-binding claims once made for chitosan weight-loss supplements have not been translated into robust human evidence, and a controlled trial of chitosan supplementation in men and women found no significant effect on fat absorption.

Where marine biopolymers may have their most immediate practical impact is as delivery vehicles rather than as active ingredients themselves. Because alginates gel gently in the presence of calcium and chitosan is mucoadhesive and forms polyelectrolyte complexes with anionic polymers, the two are natural partners for encapsulation. The review describes alginate-membrane-modified nanochitosomes that stabilize apricot kernel-derived peptides with ACE-inhibitory activity, chitosan-alginate nanocarriers that control the release of therapeutic peptides, and alginate hydrogels used in everything from wound dressings to 3D bioprinting scaffolds. Encapsulation protects sensitive bioactive compounds from degradation in the stomach, masks undesirable flavors, and can be engineered to release payloads only when they reach the intestine, where absorption is most favorable. This carrier function may prove to be the bridge that carries marine biopolymers into commercial nutraceutical products even while their direct health effects await clinical confirmation.

Safety and standardization emerge as the review’s central caveats. Extraction yields that swing by a factor of three between studies signal a field that has not converged on reproducible manufacturing. Contaminant control is a genuine concern for any marine-derived ingredient, since shellfish waste and seaweeds can concentrate heavy metals, persistent organic pollutants, and pathogenic microbes from their environment. The authors also note lingering scientific debate around degraded carrageenan and inflammatory effects reported in some animal studies, underscoring the need for careful molecular-weight characterization and food safety assessment before new applications reach consumers. Their prescription is straightforward but demanding: standardized extraction and characterization protocols, rigorous contaminant screening, formal food safety evaluation, and, above all, well-designed randomized human trials to replace the current patchwork of in vitro and animal findings.

Even with those caveats, the trajectory is unmistakable. Global seafood processing generates millions of tonnes of shells, skins, bones, and heads every year, most of which are discarded or sold as low-value animal feed, and seaweed farming is expanding rapidly as a sustainable source of biomass that requires no freshwater, fertilizer, or arable land. Converting this waste stream into chitosan, collagen, alginate, and agar represents exactly the kind of circular bioeconomy that food systems worldwide are scrambling to build. The review’s authors conclude that marine biopolymers show considerable nutraceutical potential, and the evidence they assemble supports that verdict, provided the field resists the temptation to oversell preclinical results. If the coming decade delivers the standardized processes and human trials the authors call for, the humble shrimp shell and the lowly green seaweed may find themselves among the most valuable raw materials in functional food science, transforming what was once waste into the backbone of a new generation of ocean-derived health products.

Subject of Research: Marine-derived biopolymers and their potential applications as nutraceuticals

Article Title: Marine-derived biopolymers – the wider prospects as nutraceuticals

Article References: Sofi, F. R., Kumar, L. R. G., Sannejal, A. D., Aakila, Manjunatha, K. G., Surasani, V. K. R., Behere, G. S., Saba, K., Maqbool, H., Hussain, T., & Pathak, N. (2026). Marine-derived biopolymers – the wider prospects as nutraceuticals. Polymer Bulletin, 83(12), Article 650. https://doi.org/10.1007/s00289-026-06696-9

Image Credits: AI Generated

DOI: 10.1007/s00289-026-06696-9

Keywords: marine biopolymers, nutraceuticals, chitosan, alginate, collagen, gelatin, agar, carrageenan, ulvan, green extraction, functional foods, fishery waste valorization

The central challenge in biopolymer packaging has always been performance. Films made from pectin, starch or other natural polysaccharides are renewable and compostable, but they typically fall short of petroleum-based plastics in the properties that matter most: resistance to water, barrier function against gases and mechanical strength. Multilayer designs help, because each layer can be optimized for a different function, yet bonding dissimilar biopolymer layers together without synthetic adhesives remains difficult. The Algerian team approached this problem at the molecular level, using a mild pectinase enzyme treatment to remodel the interface between the film’s two layers rather than relying on chemical crosslinkers.

The film architecture is deliberately asymmetric. The inner layer is made of pectin extracted from orange peel waste, and it is here that the researchers embedded microcapsules derived from Saccharomyces cerevisiae, common baker’s yeast. These yeast cells were plasmolyzed, a process that shrinks the cytoplasm away from the cell wall and creates internal voids that can be loaded with bioactive molecules. When the team introduced orange peel phenolic extracts into these plasmolyzed cells, they achieved an encapsulation efficiency of 85.4 plus or minus 2.1 percent, a remarkably high figure that means most of the valuable antioxidant cargo was successfully locked inside the yeast shells rather than lost during processing.

The outer layer of the film is a composite of carrageenan, chitosan and beeswax, a combination chosen for its hydrophobic character and film-forming ability. Beeswax in particular is known to boost water vapor resistance, while chitosan contributes antimicrobial activity and carrageenan provides a negatively charged polysaccharide network that can interact electrostatically with the positively charged chitosan. The result is a natural, food-contact-compatible barrier layer that shields the inner pectin matrix and its encapsulated antioxidants from the humid outside world.

The enzymatic step is where the design becomes genuinely synergistic. Before casting the outer layer, the researchers treated the pectin surface with a mild dose of pectinase, an enzyme that cleaves the chains of galacturonic acid that make up pectin. Rather than degrading the film, this controlled micro-hydrolysis created new chain ends and exposed reactive groups precisely at the interface. The team quantified this effect by measuring reducing sugars, which rose to 8.63 plus or minus 0.47 milligrams of glucose equivalents per gram, and galacturonic acid, which reached 4.86 plus or minus 0.28 milligrams per gram. These newly generated carboxyl groups formed stronger hydrogen bonds and ionic interactions with the carrageenan-chitosan layer, dramatically improving interlayer cohesion without any synthetic chemistry.

The performance gains measured in the composite films are striking. Compared with a control film lacking the microcapsules, water solubility dropped from 39.0 percent to 19.0 percent, meaning the film is far more stable when exposed to moisture. The water vapor transmission rate fell from 6.49 to 3.10 times ten to the minus six grams per square millimeter per hour, roughly a halving of moisture permeability. Oxygen permeability fell even more dramatically, from 8.9 to 3.8 times ten to the minus seven grams per square meter per hour, a critical improvement for packaging that must protect oxidation-sensitive foods such as oils, nuts and meats. Perhaps most impressively, Young’s modulus, a measure of stiffness, increased more than eightfold, from 1.20 to 9.96 megapascals, indicating that the yeast capsules and the engineered interface act as reinforcing elements within the polymer matrix.

Structural analyses confirmed what the mechanical tests suggested. Fourier-transform infrared spectroscopy revealed enhanced intermolecular interactions, particularly hydrogen bonding between the polysaccharide chains and the phenolic cargo. Scanning electron microscopy showed a more homogeneous matrix with the yeast microcapsules well dispersed rather than clumped. X-ray diffraction preserved the characteristic crystalline peaks of the base polymers but showed the crystallinity index falling from 12.40 percent in the control to 7.06 percent in the capsule-loaded film, a partial amorphization that improves flexibility and guest-molecule dispersion without destroying the underlying crystalline phase. Thermal analysis added further reassurance, demonstrating improved stability at elevated temperatures, an important consideration for processing and storage.

One of the most commercially relevant findings concerns how the encapsulated antioxidants behave over time. Free phenolic extracts incorporated directly into films tend to burst out quickly, providing a short-lived antioxidant effect. In contrast, the yeast-encapsulated phenolics diffused out slowly in a pH-dependent manner, sustaining antioxidant activity for much longer. This controlled-release behavior means the packaging could actively protect food throughout its shelf life, scavenging the free radicals that drive rancidity and oxidative spoilage. Because the release rate depends on pH, the film could even be tuned to respond to the chemical environment of the packaged product, a step toward intelligent, responsive packaging systems.

The broader significance of the work lies in its circular economy logic. Orange peels supply both the pectin matrix and the antioxidant payload, yeast provides a cheap, food-grade and biodegradable capsule material, and beeswax and carrageenan complete the barrier layer, all from renewable or byproduct streams. The enzyme treatment replaces petrochemical adhesives with a biological process that operates under mild conditions. The authors report that the study received no external funding and declare no competing interests, and they acknowledge support from the Institute of Materials Science of Barcelona, ICMAB-CSIC, where scanning electron microscopy and thermal analysis experiments were carried out during a short research stay.

Scaling such systems from the laboratory to industrial production will require optimization of extraction yields, enzyme dosing and film casting at larger formats, along with food-safety validation and lifecycle assessment. But the conceptual advance is clear: by treating waste as a design feedstock and using enzymes and living cells as fabrication tools, packaging can be made stronger, more protective and functionally active simultaneously. If such multifunctional biodegradable films reach commercial maturity, the orange peel thrown away after breakfast juice could one day wrap the food on the shelf, protecting it with the very antioxidants the fruit itself produced.

Subject of Research: Development of bilayer biopolymer packaging films from orange peel waste using enzymatic interfacial engineering and yeast microencapsulation of polyphenols

Article Title: Synergistic Enzymatic Interfacial Engineering and Yeast Microencapsulation of Orange Peel Polyphenols for the Valorization in Advanced Bilayer Biopolymer Films

Article References: Laib, I., Laib, D. E., & Chenchouni, H. (2026). Synergistic Enzymatic Interfacial Engineering and Yeast Microencapsulation of Orange Peel Polyphenols for the Valorization in Advanced Bilayer Biopolymer Films. Waste and Biomass Valorization. https://doi.org/10.1007/s12649-026-03781-y

Image Credits: AI Generated

DOI: 10.1007/s12649-026-03781-y

Keywords: orange peel waste, biopolymer films, yeast microencapsulation, pectinase, polyphenols, active packaging, carrageenan, chitosan, beeswax, antioxidant release, food packaging, waste valorization

MASLD is no longer a niche concern. It encompasses a spectrum running from simple hepatic steatosis to the inflammatory, fibrotic condition known as metabolic dysfunction-associated steatohepatitis, and it is tightly coupled to obesity and type 2 diabetes. Treatment options remain frustratingly thin. The recent approval of resmetirom, a thyroid hormone receptor-beta agonist that became the first FDA-approved medication for nonalcoholic steatohepatitis, marked a genuine milestone, but clinicians still lack cheap, safe, preventive strategies for the vast population of patients with early disease. That gap has pushed researchers toward nutraceuticals—food-derived compounds with drug-like activity—and toward the gut microbiome as a therapeutic target in its own right.

The gut–liver axis sits at the center of the new review’s argument. The liver receives the portal blood supply directly from the intestine, along with everything the gut microbes produce: short-chain fatty acids, bile acid derivatives, trimethylamine N-oxide, indole compounds, endotoxins, and ethanol made by bacteria themselves. When the microbial community falls into dysbiosis—a state that clinical studies have repeatedly linked to the severity of fatty liver disease—the balance of these metabolites tips. Barrier function in the intestine weakens, bacterial lipopolysaccharide leaks into circulation, hepatic inflammation and oxidative stress escalate, and hepatocytes accumulate fat. Some evidence even implicates high-alcohol-producing Klebsiella pneumoniae in driving fatty liver in non-drinkers, underscoring how directly microbial chemistry can become hepatic pathology.

What makes marine polysaccharides different from the plant fibers already celebrated in nutrition? The authors emphasize structural chemistry. Land-based fibers are built largely from neutral sugars, whereas marine polysaccharides—fucoidans from brown seaweeds, carrageenans from red algae, ulvans from green algae, agars and porphyrans from Porphyra, alginates from kelp, chitosan from crustacean shells, and sulfated glycans from sea cucumbers—carry sulfate groups and uronic acids, form complex glycosidic linkages, adopt diverse conformations, and span broad molecular-weight distributions. Those features mean that human enzymes cannot digest them, but specific gut bacteria can, using elaborate carbohydrate-active enzyme systems called polysaccharide utilization loci. The result is selective feeding: particular structures recruit particular microbial taxa, shifting community composition in reproducible, mechanism-linked ways.

Human populations provide a striking natural experiment. Japanese individuals harbor gut bacteria that acquired genes for digesting marine sulfated polysaccharides from marine Bacteroides via horizontal gene transfer, a discovery that revealed how the microbiome can expand its metabolic repertoire when the diet supplies novel glycans. Subsequent genomic work identified multiple independent transfer events that seeded seaweed-digestion genes into human gut bacteria. This capacity for adaptation is precisely what marine polysaccharide therapy hopes to exploit: by supplying glycans that only beneficial consumers can process, these compounds act as targeted prebiotics, enriching organisms such as Lactobacillus, Akkermansia muciniphila, and beneficial Bacteroides species while suppressing inflammatory lineages.

The downstream metabolic consequences are where the review gets technically ambitious. Fermentation of marine polysaccharides yields short-chain fatty acids—acetate, propionate, and butyrate—which nourish colonocytes, strengthen tight junctions, and engage G-protein-coupled receptors that regulate glucose homeostasis and appetite. Simultaneously, polysaccharide-driven changes in bile acid metabolism alter signaling through the nuclear receptor FXR and the membrane receptor TGR5, pathways now recognized as central to hepatic lipid handling, energy expenditure, and inflammation. At the hepatocyte level, marine polysaccharides and their oligosaccharide fragments activate AMPK and PPARα, the master switches of fatty acid oxidation, and engage the Nrf2 antioxidant program, directly countering the lipid accumulation and oxidative stress that define steatohepatitis.

Preclinical evidence illustrates the breadth of this approach. Fucoidan from Sargassum fusiforme alleviated high-fat diet-induced obesity and insulin resistance while improving the gut microbiota profile and hepatic oxidative stress. Alginate oligosaccharides relieved insulin resistance and fatty liver in mice through microbiota-mediated bile acid regulation. Iota-carrageenan tetrasaccharide reduced liver lipid accumulation via the bile acid–FXR–SHP/PXR pathway, and chitosan oligosaccharides attenuated steatosis, inflammation, and oxidative stress in diet-induced obese mice. Sea cucumber fucosylated chondroitin sulfate modified gut microbiota to prevent obesity, and oyster polysaccharide ameliorated hepatic oxidative stress through the bile acid–FXR–AMPKα axis. Porphyran from discolored nori prevented metabolic syndrome through a microbiota–bile acid–ceramide pathway, while ulvan oligosaccharides regulated lipid metabolism in high-fat diet-fed animals.

Clinical data, though still early, are encouraging. A randomized, double-blinded, placebo-controlled trial found that chitosan supplementation improved liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease. Chitooligosaccharides rebalanced gut microorganisms and their metabolites in NAFLD patients, and Icelandic trial data showed that chitosan supplementation favorably altered the gut microbiota in healthy women. A fucoidan extract improved insulin resistance and cardiometabolic markers in obese, nondiabetic subjects in a randomized controlled trial, and fucoidan has also demonstrated clinical efficacy as an adjunct in Helicobacter pylori eradication, hinting at broad microbiome-modulating potential. Trials combining Laminaria japonica with probiotics improved intestinal microbiota in human volunteers, and fecal microbiota transplantation protocols now being tested in steatohepatitis underscore how central microbial manipulation has become to the field.

The review is candid about the obstacles between laboratory promise and clinical reality. Marine polysaccharides are structurally heterogeneous, and batch-to-batch variation in sulfation pattern, molecular weight, and monosaccharide composition makes standardization difficult—yet those same variables appear to determine biological activity, as shown by recent synthetic fucoidan libraries that enabled systematic structure–function comparisons. Safety questions also persist, particularly for carrageenan, a widely used food additive whose degraded forms have been associated with intestinal inflammation in some animal and human studies, even as food-grade material appears benign in others; clarifying this controversy is essential for consumer confidence. Contaminant burdens in macroalgae, including arsenic, cadmium, lead, and mercury, require careful regulatory alignment between producing and consuming regions. Dosing, bioavailability, and long-term effects remain underexplored.

Nevertheless, the authors position marine polysaccharides as uniquely advantaged relative to terrestrial fibers: their unusual chemistries reach microbial niches that common fibers cannot, and their pleiotropic effects—spanning short-chain fatty acid production, bile acid signaling, barrier protection, endocrine modulation, and direct hepatic pathway activation—map precisely onto the multi-organ pathophysiology of MASLD. As sequencing technologies make it possible to identify exactly which bacteria consume which glycans, and as controlled synthesis enables reproducible materials, the field is converging on a rational design framework: engineer polysaccharide structures to recruit defined beneficial communities and thereby steer the gut–liver axis away from disease. If clinical trials confirm the early human signals, the humble slime of the seashore may prove to be one of the most practical liver medicines of the coming decade—harvested not from a pharmaceutical plant, but from the wrack line.

The scale of the unmet need gives this research agenda its urgency. Population studies suggest that roughly a third of adults in many industrialized countries carry hepatic steatosis, with prevalence climbing in children and adolescents, yet most affected individuals are identified only incidentally or through rising cardiometabolic risk factors. Because early-stage disease is largely asymptomatic, an intervention that could be delivered safely as a dietary supplement—and taken for years—would address a far larger population than any prescription drug realistically can.

The prebiotic framing deserves careful attention. Classic prebiotics such as inulin and fructooligosaccharides are fermented broadly by common saccharolytic organisms, which can limit how precisely a community can be steered. Sulfated marine glycans, by contrast, demand specialized enzyme machinery, so only microbes equipped with the appropriate sulfatases and carbohydrate-active enzymes can access them. This substrate specificity is the theoretical basis for precision microbiome editing through diet, and it explains why the authors treat structural chemistry rather than fiber content as the decisive design variable.

Molecular weight emerges as a recurring theme in the preclinical literature. High-molecular-weight polymers are often poorly soluble and difficult for microbes to process, while controlled depolymerization into oligosaccharides frequently enhances water solubility, bioactivity, and fermentability. Several of the most striking animal results cited in the review involve oligosaccharide fragments rather than intact polymers, suggesting that processing technology—enzymatic degradation, controlled hydrolysis, or even synthetic chemistry—will be as important as source selection for future products.

Practical considerations also favor the field. Many marine polysaccharides already hold food additive or generally recognized as safe status in major jurisdictions, and industrial supply chains for carrageenan, alginate, and agar are mature, which could shorten the path from bench to consumer. Seasonal and geographic variation in seaweed composition remains a genuine hurdle, but cultivation of defined macroalgal strains under controlled conditions offers a route to more consistent raw material than wild harvest alone.

What remains most persuasive is the convergence of mechanisms: microbial selection, metabolite generation, barrier reinforcement, and direct hepatic signaling all point in the same direction. Few nutraceutical candidates offer that degree of mechanistic coherence, and few target a disease with such a large and growing affected population.

Subject of Research: Marine polysaccharides as nutraceutical modulators of the gut microbiome and gut–liver axis in metabolic dysfunction-associated steatotic liver disease

Article Title: Marine polysaccharides: promising nutraceuticals for metabolic dysfunction-associated steatotic liver disease as unique and potent modulator of gut microbiome

Article References: Pan, Y., Zhang, R., & Chen, Y. (2026). Marine polysaccharides: promising nutraceuticals for metabolic dysfunction-associated steatotic liver disease as unique and potent modulator of gut microbiome. Food Science and Biotechnology. https://doi.org/10.1007/s10068-026-02283-w

Image Credits: AI Generated

DOI: 10.1007/s10068-026-02283-w

Keywords: marine polysaccharides, MASLD, gut microbiome, gut–liver axis, fucoidan, carrageenan, ulvan, chitosan, short-chain fatty acids, bile acid signaling, nutraceuticals, fatty liver disease

The chemical arsenal on display is remarkable in its diversity. Brown algae of the class Phaeophyceae are dominated by phlorotannins, polyphenolic polymers built from phloroglucinol units and linked through ether, phenyl and dibenzodioxin bonds. The degree of polymerisation governs both solubility and bioactivity, and roughly 220 phlorotannin entries are catalogued in the Seaweed Metabolite Database. Red algae, which show the highest fingerprint diversity in that database with 645 recorded metabolites, specialise in sulfated galactans such as carrageenans and in an extraordinary array of halogenated terpenes and acetogenins, exemplified by compounds like elatol and isolaurinterol from the genus Laurencia. Laurencia dendroidea alone has yielded more than 40 unique terpenoids, supported by 21 identified terpene synthase genes. Green algae contribute sulfated polysaccharides known as ulvans, alongside specialised peptides with emerging biomedical relevance.

The antimicrobial mechanisms underlying these compounds are mechanistically distinct from those of classical antibiotics, which is precisely what makes them attractive in an era of multidrug resistance. Phlorotannins act through a combination of membrane disruption, chelation of essential metal ions and the generation of oxidative stress, while simultaneously interfering with quorum sensing—the chemical communication system bacteria use to coordinate virulence factor production and biofilm formation. Studies of phlorotannins from Hizikia fusiforme, for example, demonstrated both antimicrobial and anti-quorum-sensing activity. Halogenated terpenoids from Laurencia species show potent activity against Staphylococcus aureus and Vibrio species, an effect attributed to their lipophilic and electrophilic chemical character. Sulfated polysaccharides such as carrageenan and fucoidan take a different tack, interfering with bacterial adhesion and colonisation by altering electrostatic interactions at the microbial cell surface. Because these molecules hit multiple cellular targets at once, the risk of resistance emergence may be inherently lower than for single-target drugs.

The antiviral and antifungal records of these metabolites are equally striking. Sulfated polysaccharides including carrageenans and agars can mimic host cell receptors, preventing enveloped viruses from attaching to and entering target cells, while phlorotannins inhibit viral proteases and polymerases by binding to key viral proteins; a phlorotannin-rich extract of Ascophyllum nodosum has been shown to inhibit influenza infection. Against fungi, phlorotannins compromise cell wall integrity and block ergosterol biosynthesis—pathways reminiscent of synthetic antifungals but potentially less prone to resistance—while elatol exerts fungicidal effects through membrane disruption and oxidative stress. Antiparasitic activity has been traced to fatty acid derivatives and phenolic compounds that interfere with parasite metabolism and membrane stability. The review notes, however, that most of this evidence remains in vitro, and that in vivo validation in relevant animal models is urgently needed before clinical deployment.

Beyond direct pathogen killing, the most transformative dimension of the review concerns microbiome engineering. Seaweed-derived polysaccharides such as fucoidans, laminarins and ulvans act as selective prebiotics, enriching beneficial taxa such as Bifidobacterium, Lactobacillus and Akkermansia while suppressing opportunistic members of the Bacteroidetes and Proteobacteria. In broiler chickens, dietary inclusion of 5 to 10 grams per kilogram of seaweed polysaccharides improved intestinal architecture, microbial balance and weight gain in a dose-dependent manner. In pre-weaning Holstein calves, seaweed polysaccharide supplementation increased the abundance of Prevotella and Succiniclasticum, reduced diarrhoea incidence, lowered systemic inflammatory markers including IL-18, TNF-α and IFN-γ, and elevated immune effectors such as complement C3 and IgM. These effects were linked to increased abundance of gut microbes involved in alkaloid and glucocorticoid biosynthesis, suggesting a coordinated immunometabolic mechanism.

The ecological sophistication of these interactions extends to the seaweeds themselves, which the authors describe as holobionts—integrated units of alga plus microbiota. Macroalgae such as Agarophyton vermiculophyllum engage in what researchers call chemically mediated microbial gardening, dynamically attracting symbiotic microbes and excluding pathogens depending on environmental conditions like salinity. Exometabolomic analyses show that macroalgae release distinctive nitrogenous and lipid-rich compounds that support microbial colonisation and nutrient cycling, and genomic surveys have identified more than 4,400 polysaccharide utilisation loci and roughly 8,800 biosynthetic gene clusters in algae-associated bacteria—clear evidence of co-evolutionary adaptation for metabolising algal substrates. Many metabolites previously credited to seaweeds are in fact synthesised or chemically modified by their associated microbiota, a realisation that reshapes how such compounds should be discovered, sourced and standardised.

Biotechnology is now converging to solve the longstanding problems that have kept these compounds out of the clinic. On the extraction side, green technologies—ultrasound-assisted extraction, microwave-assisted extraction, supercritical fluid extraction and enzymatic hydrolysis—are replacing crude solvent methods, improving yield, selectivity and sustainability. Natural deep eutectic solvents optimised for Fucus vesiculosus have delivered high-purity phlorotannins validated by HPLC-MS profiling. Nanotechnology offers solutions to the chronic bioavailability problem: red seaweed-derived nanoparticles provide biocompatibility and controlled release, while silver-based metal–organic frameworks embedded in κ-carrageenan hydrogels combine antibacterial action with the mechanical properties needed for wound dressings. One carrageenan–silver hydrogel composite has already entered commercial wound-healing use, and fucoidan–chitosan nanoparticles are in Phase I trials for targeted colorectal delivery of curcumin.

Synthetic biology is arguably the most ambitious frontier. Metagenomic mining of seaweed microbiota has illuminated vast biosynthetic potential in genera such as Pseudoalteromonas and Vibrio, and CRISPR-based editing combined with heterologous expression in fast-growing chassis like Vibrio natriegens is enabling high-yield biosynthesis of halogenated meroterpenes. The red algal lectin Griffithsin, produced by expression in Nicotiana benthamiana plants, has achieved preclinical validation as a topical antiviral microbicide, demonstrating industrial scalability. Bioinformatic platforms such as antiSMASH and BiG-SCAPE are accelerating the annotation of novel gene clusters encoding alkaloids, terpenoids and glycosides. On the regulatory side, the strongest proof of concept remains sodium oligomannate (GV-971), an oligosaccharide derived from marine algae that received conditional approval in China for Alzheimer’s disease following a 36-week Phase 3 trial—although the review stresses that broader global endorsement awaits more extensive chronic toxicity data.

The authors are candid about the obstacles that remain. Metabolite composition varies with season, geography, salinity, light and harvest conditions; the antimicrobial activity of Ulva lactuca extracts, remarkably, fluctuates with lunar phase at harvest. Poor oral bioavailability, low gastrointestinal stability, first-pass hepatic metabolism and batch-to-batch inconsistency in crude extracts complicate pharmacokinetic modelling and regulatory approval. Structural heterogeneity in fucoidans—where sulfation patterns and molecular weight determine bioactivity—means that harmonised analytical standards are lacking. The review calls for omics-guided bioactivity mapping, standardised extraction and assay protocols, microbiome-informed therapeutic design, and sustainable cultivation systems including land-based aquaculture and integrated multi-trophic approaches that recycle nutrients by pairing seaweed farming with fish or shellfish production. Photobioreactors and controlled tank cultures, in which salinity, light and nutrient stress can be tuned to boost production of phlorotannins, fucoidan and terpenoids, offer a path to reproducible, quality-controlled biomass.

Taken together, the evidence assembled in this review paints seaweed-derived secondary metabolites as far more than a curiosity of marine natural product chemistry. They are multimodal antimicrobials capable of attacking pathogens through mechanisms that bypass existing resistance determinants; they are prebiotic scaffolds that can rebuild dysbiotic microbial communities and dampen inflammation; and they are scaffolds for nanocarriers and synthetic biology platforms that are already reaching commercial and clinical milestones. What is needed now, the authors conclude, is interdisciplinary alignment—marine biotechnologists, pharmacologists, microbial ecologists and clinicians working within shared analytical frameworks—to convert a chemically extraordinary ocean resource into dependable, evidence-based medicines for the microbiome-centred era of healthcare.

The timing of this review reflects a broader shift in how antimicrobial research is conceptualised. Rather than seeking single molecules that sterilise microbial communities, the microecological approach emphasises selective modulation—suppressing pathogens while preserving or even enriching commensal taxa. Seaweed metabolites are unusually well suited to this paradigm because their activities span both direct antimicrobial action and substrate-level nutrition of beneficial bacteria, a dual function rarely seen in conventional small-molecule antibiotics.

The taxonomic partitioning of metabolite classes among algal phyla is itself scientifically informative. The distinct biosynthetic capabilities of Phaeophyceae, Rhodophyta and Chlorophyta mean that sourcing decisions can be guided by target compound class: phlorotannins from brown algae for antioxidant and anti-quorum-sensing applications, carrageenans and halogenated terpenoids from red algae for antiviral and antibacterial purposes, and ulvans from green algae for prebiotic formulations. This phylum-specific specialisation, catalogued in resources such as the Seaweed Metabolite Database, provides a rational framework for bioprospecting programmes.

The open-access status of the review, published as volume 3, article number 7 of Discover Biotechnology, makes the full catalogue of compound classes, mechanisms and translational case studies freely available to researchers in regions where seaweed cultivation is already an established industry. The authors’ citation record, with the article already accumulating citations and thousands of accesses within weeks of publication, suggests substantial interest in microbiome-centred alternatives to conventional antibiotics. As regulatory agencies increasingly grapple with how to evaluate complex, heterogeneous natural products, the standardisation agenda outlined by Annamalai and Kolandhasamy may prove as consequential as the molecules themselves.

Subject of Research: Bioactive secondary metabolites from marine macroalgae for antimicrobial action and microbiome modulation

Article Title: Marine macroalgal metabolites in microbial modulation for next-generation microecological therapeutics

Article References: Annamalai, A., & Kolandhasamy, P. (2026). Marine macroalgal metabolites in microbial modulation for next-generation microecological therapeutics. Discover Biotechnology, 3(1), Article 7. https://doi.org/10.1007/s44340-025-00047-6

Image Credits: AI Generated

DOI: 10.1007/s44340-025-00047-6

Keywords: marine macroalgae, seaweed metabolites, antimicrobial resistance, phlorotannins, sulfated polysaccharides, fucoidan, carrageenan, microbiome modulation, prebiotics, synthetic biology, nanocarriers, microecological therapeutics